Publication date: Feb 13, 2025
| Concepts | Keywords |
|---|---|
| Ciprofloxacin | clinical assessment |
| Severe | drug-drug interactions |
| Vaccines | inflammatory bowel disease |
| oral therapies | |
| ulcerative colitis |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | drug interactions |
| disease | MESH | ulcerative colitis |
| drug | DRUGBANK | Ozanimod |
| drug | DRUGBANK | Didanosine |
| drug | DRUGBANK | Tofacitinib |
| drug | DRUGBANK | Ondansetron |
| drug | DRUGBANK | Azithromycin |
| drug | DRUGBANK | Hydrocodone |
| drug | DRUGBANK | Fentanyl |
| drug | DRUGBANK | Salbutamol |
| drug | DRUGBANK | Ciprofloxacin |
| drug | DRUGBANK | Metronidazole |
| drug | DRUGBANK | Infliximab |
| drug | DRUGBANK | Fluconazole |
| drug | DRUGBANK | Azathioprine |
| disease | MESH | inflammatory bowel disease |
| pathway | KEGG | Inflammatory bowel disease |
Original Article
(Visited 1 times, 1 visits today)